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Abstract 
In a first series of experiments a glucose oxidase-based 
biosensor implanted in the striatum of freely moving rats 
was used to determine the concentration of brain 
extracellular (ECF) glucose in two distinct ways. With a 
modification of the zero-net-flux method, in which 
different concentrations of glucose are infused through a 
dialysis probe glued to the biosensor, the concentration at 
which there was no change in glucose current was 
calculated by regression analysis; this gave an ECF 
concentration of 351 ± 16 µM. The concentration 
calculated from the basal current and the in vitro 
calibration of the biosensor was not significantly different 
from this. The basal extracellular glucose concentration 
determined by either method remained constant over a 
period of several days.  In a second series of experiments 
rats were implanted in the striatum with a Pt/Ir electrode 
for measurement of regional cerebral blood flow (rCBF, 
H2 clearance technique), a carbon paste electrode for 
monitoring tissue oxygen, and a glucose biosensor for 
monitoring extracellular glucose. There was a parallel 
increase in rCBF and oxygen in response to neuronal 
activation (5 min tail pinch). During the neuronal 
activation there was a decrease in ECF glucose which was 
followed by a slow rise that took 30 min to return to basal 
levels. Finally, a group of rats implanted with a combined 
glucose biosensor and dialysis probe were given a 5 min 
tail pinch while the dialysis probe was perfused with 
either artificial cerebrospinal fluid (aCSF) alone or aCSF 
with the addition of the β-adrenoceptor antagonist 
propranolol. Perfusion with aCSF once again produced an 
initial reduction in extracellular glucose, which was co-
extensive with the period of stimulation, followed by a 
delayed and long-lasting increase in glucose. Propranolol 
had no effect on basal levels of glucose but suppressed the 
delayed increase. These results suggests that extracellular 
glucose in the brain is not derived directly from the blood 
vascular system but from some other source which is 
most likely to be astrocytes. 
 
1  INTRODUCTION 
According to the classical model of brain metabolism 
increased energy requirements are met by an increase in 
blood flow that delivers oxygen and glucose to the 
extracellular compartment. In this model there is close 
coupling between blood flow and the delivery and 
utilisation of glucose and oxygen. This has been replaced 
by a model in which energy metabolism is 
compartmentalised; increased energy requirements of 
activated neurones are met by neuronal utilisation of 
lactate not glucose, the lactate being provided by 
astrocytic glycolysis stimulated by the uptake of 
glutamate. Evidence in support of this model has 
principally come from in vitro experiments using primary 
cell cultures [1], brain slices [2], and more recently from 
NMR studies [3]. These techniques, however, cannot 
provide the temporal relationships of the various 
processes.  
 
With the development of in vivo methods for monitoring 
changes in metabolic substrates in unanaesthetised 
animals it has become possible to relate changes in 
neuronal activity, in selected brain regions, with changes 
in brain metabolism. The use of microdialysis with 
enzyme-based assays for glucose and lactate has 
demonstrated a stimulation-dependent increase in lactate 
linked to glutamate uptake [4, 5], as well as a dissociation 
between increases in rCBF and increases in ECF glucose 
[4]. While these results support the use of lactate as an 
energy substrate they also suggest that glucose in the 
extracellular compartment is not derived directly from the 
blood vascular compartment. This has led to some 
controversy among proponents of the new compartment 
model concerning the immediate source of extracellular 
glucose, since in in vitro experiments astrocytes in culture 
export lactate but not glucose [6], which has led to the 
suggestion that glucose enters the extracellular space 
directly from the blood stream [7]. 
 
Microdialysis however does have several limitations 
including a time resolution of 2-3 min and the fact that the 
concentration of analytes in the dialysate depends on a 
variable in vivo recovery [8]. A growing number of new 
methodologies are being developed to study 
neurochemical phenomena in the living brain with high 
time resolution. One such set of techniques focuses on the 
detection of substances using amperometric electrodes 
and voltammetric techniques in vivo [9]. By implanting a 
microvoltammetric electrode (sensor) in a specific brain 
region, applying a suitable potential profile and recording 
the resulting faradaic current, changes in the 
concentration of a variety of substances in the 
extracellular fluid can be monitored with a sub-second 
time resolution over extended periods. This allows 
investigations of the functions and roles of specific 
neurochemicals in neuronal signalling, drug actions, and 
well-defined behaviours, with a time resolution not 
presently available with other methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic illustration of a Pt/PPD/GOx biosensor. The 
glucose oxidase (GOx) catalysed oxidation of glucose (Gluc) yields 
H2O2. The small H2O2 molecules can diffuse easily to the Pt surface to 
be electro-oxidised with a characteristic fast response time (see Figure 
3C). Access to the metal by larger electroactive species, such as 
ascorbic acid (AA), is selectively restricted by the poly(o-
phenylenediamine) (PPD) layer. 
 
Recently, the development by the author, of a glucose 
biosensor for real-time voltammetry in vivo has provided 
100% recovery and a sub-second time resolution [10]. 
This device is an amperometric biosensor (a device 
incorporating a biological sensing element, such as an 
enzyme, that is either intimately connected to or 
integrated within a transducer, e.g. an electrode) prepared 
by immobilising glucose oxidase (GOx) onto a platinum 
microelectrode by trapping the enzyme during 
electropolymerisation of poly(o-phenylenediamine) 
(PPD) on the electrode surface (see Figure 1) [11]. A 
detailed characterisation of this biosensor was first carried 
out in vitro (Department of Chemistry, University College 
Dublin) [11,12]. The sensor was modified and fine-tuned, 
implanted into rat brain (University Laboratory of 
Physiology, Oxford), and the following characteristics 
established in vivo [13]: (i) high sensitivity to glucose; (ii) 
freedom from fouling by endogenous matrix 
macromolecules (lipids and proteins) in the target 
environment; (iii) insignificant interference from reducing 
agents, especially ascorbic acid which is normally present 
in high concentration; and (iv) insensitivity to changes in 
oxygen partial pressure. This glucose biosensor was 
subsequently used to study brain energy metabolism in 
vivo, on its own, and in combination with other 
microelectrochemical sensors: tissue oxygen levels were 
monitored using a modified carbon paste electrode and a 
specially designed computer-based voltammetric 
technique (differential double pulse amperometry) [14]; 
measurements of regional cerebral blood flow (rCBF) 
were carried out using a Pt electrode and a modified form 
of the hydrogen clearance technique designed for use in 
freely moving animals [15]. 
 
In this review paper various results are presented 
highlighting the application of this new technology as an 
important approach in the elucidation of the mechanisms 
of energy supply and utilisation in the mammalian brain. 
 
2  MATERIALS AND METHODS 
Details of Materials and Methods can in be found in 
previous publications: Chemicals and Solutions [10,13]; 
Working Electrode Preparation [10,13]; Microdialysis 
Probe Construction [10]; Instrumentation and Software 
[10,13]; In Vitro Conditioning and Characterisation of 
Pt/PPD/GOx Electrodes [13]; Surgical Procedures 
[10,13]; Experimental Conditions [13]; Voltammetric 
Techniques In Vivo [13]; Physiological Stimulation [15]. 
 
3  RESULTS AND DISCUSSION 
3.1.  ECF Concentration 
As outlined in the Introduction there is some controversy 
concerning the immediate source of glucose in the 
extracellular compartment [16]. An accurate 
determination of the true extracellular concentration is a 
critical step in the resolution of this controversy. The 
concentration of brain extracellular glucose has 
previously been calculated from whole brain glucose and 
the volume of the extracellular compartment [17]; such 
measurements have estimated the extracellular glucose 
concentration as 2.0 mM. More recently, brain 
extracellular glucose has been monitored in vivo using 
microdialysis. However, it has been shown, using 
microdialysis, that the calculation of the concentration of 
glucose in the extracellular compartment from the 
concentration in the dialysate requires a knowledge of the 
in vivo recovery, which cannot be derived from the in 
vitro recovery of the probe [8]. The zero-net-flux (ZNF) 
method of Lönnroth [18] provides a figure for both the 
extracellular concentration and the in vivo recovery. 
Application of the ZNF method has given figures of 0.47 
mM [19] and 350 µM [8] in the striatum of 
unanaesthetised rats and 3.3 mM in the cortex of 
anaesthetised rats [20]. 
 
The following experiments utilised a recent modification 
of the ZNF method in which an implanted glucose 
biosensor was combined with a dialysis probe [21] to 
determine the extracellular concentration of glucose in the 
striatum of freely moving rats. This value was then 
compared with that derived from calculations using the in 
vitro calibration of the biosensor. 
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Figure 2. A typical regression curve constructed from a zero-net-flux 
experiment during which glucose solutions ranging from 100 to 1,000 
µM were perfused in random order through a dialysis probe (combined 
with a glucose biosensor) at a flow rate of 2 µL/min.   
 
Combined Pt/PPD/GOx sensors and microdialysis probes 
were implanted in the right striatum of freely moving rats 
and the modified Lönnroth ZNF method used to 
determine the true extracellular concentration of glucose 
in situ. The experimental procedure has been described in 
a previous publication [ 10]. Perfusion of glucose 
concentrations lower or higher than that in the ECF 
resulted in a net loss or gain from the tissue into the 
dialysis probe and was characterised by a decrease or 
increase in the Pt/PPD/GOx current. Random perfusion of 
concentrations above and below the point of ZNF resulted 
in quite rapid changes in the glucose current which 
reached a steady-state usually within 10-15 min. 
However, once perfusion was stopped the return to 
baseline or control values was longer for the higher 
concentrations:  26 ± 3 min for 1,000 µM glucose (n = 4, 
6 determinations) and 6 ± 1 min for aCSF (n = 4, 6 
determinations). With certain concentrations there was 
little or no change in the glucose current, indicating that 
these concentrations were close or equal to the ECF 
concentration. As the animals were freely-moving there 
were often periods during the perfusion of glucose when 
the animals were quite active (e.g. feeding) and the 
glucose current required longer periods of time to reach 
steady-state conditions. Linear regression analysis of a 
plot of the observed change in current (∆I) versus 
perfused concentration yielded a straight line (r2 = 0.98 ± 
0.01) and a mean ZNF point of 351 ± 16 µM (n = 4, 11 
determinations) which represents the extracellular 
concentration of glucose (see Figure 2). In ZNF 
experiments carried out on two consecutive days (1 and 2) 
in four animals the calculated extracellular concentrations 
were 373 ± 12 µM for day 1 and 358 ± 19 µM for day 2, a 
difference which was not statistically significant (P > 
0.57). This is in contrast to earlier microdialysis data, 
where dialysate glucose levels showed a progressive 
decrease [19]. 
 
In the alternative approach basal glucose levels were 
calculated from the baseline currents recorded in vivo and 
the in vitro calibration data. These values were compared 
with those obtained using the ZNF method. The in vitro 
sensitivity of the Pt/PPD/GOx electrodes for glucose was 
61 ± 25 nA/mM (n = 4). The difference in glucose 
concentration calculated from the in vitro calibration of 
the four biosensors and the value calculated from ZNF 
experiments carried out 24 h after implantation was 48 ± 
86 µM, a difference not different from 0 (n = 4, 4 
determinations, P = 0.61). When the comparison was 
made between basal concentrations determined by these 
two methods on days 1 and 2 after implantation the 
difference was 19 ± 49  µM (n = 4, 8 determinations, P = 
0.74). Similarly, there was no significant difference (P > 
0.38) in the extracellular concentration calculated from in 
vitro calibrations for day 1 (422 ± 81 µM, n = 4) and day 
2 (398 ± 69 µM, n = 4). 
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These findings have several implications. The first is that 
there is little or no change in the sensitivity of the 
biosensor following implantation, supporting previous 
results [11]. The second is that the close agreement 
indicates that in vivo the biosensor current represents only 
glucose. The third is that in contrast to microdialysis, 
measurements with the implanted biosensor provide a 
direct, real-time measure of the extracellular 
concentration of glucose. In microdialysis the delivery of 
glucose to the dialysate is by diffusion along a 
concentration gradient. In addition to the dialysis 
membrane the narrow and tortuous clefts of the 
extracellular compartment offer barriers to free diffusion 
and hence restrict the flux to the probe. Processes of 
supply and utilisation increase the concentration gradient 
and hence the flux from the brain [22]. The removal of 
glucose by microdialysis varies with flow rate, and even 
at 2 µL min-1 is 41 times greater than the removal by the 
enzyme-based biosensor. The much smaller removal flux 
of the biosensor is much more easily met by the tissue 
processes surrounding the probe. Consequently, the local 
extracellular concentration is not perturbed by the 
electrode which records the true extracellular 
concentration which can be calculated from the in vitro 
calibration. 
 
3.2.  Neuronal Activation 
Measurement of changes in rCBF were carried out at 5 
min intervals using a method described in detail in a 
previous publication [15]. The mean basal rCBF was 86.5 
± 7.9 mL/100g/min (n = 9). Figure 3A shows the rCBF 
monitored over a period of 75 min at a Pt electrode 
implanted in the left striatum. During this period two tail 
pinches were administered by attaching a paper clip to the 
rat’s tail. The 5 min tail pinch caused an increase in rCBF 
which was maximal in the first measurement after the 
onset of the tail pinch and returned to baseline levels 
within the next 1 or 2 measurements after the end of the 
tail pinch. The mean increase in rCBF was 73.4 ± 8.4 
mL/100mg/min (n = 9), which is an increase of 88 ± 11% 
above basal. 
 
Figure 3B shows the simultaneous measurement of tissue 
oxygen measured as the oxygen current at a carbon paste 
electrode implanted in the right striatum. The application 
of the tail pinch produced an immediate increase in 
oxygen current that reached a maximum at the end of the 
tail pinch and began to decrease as soon as the paper clip 
was removed. The mean baseline current was 194 ± 65 
nA and the mean increase 10.4 ± 1.7 nA (n = 9). These 
figures cannot be used to calculate the percentage change, 
since the carbon paste electrode has a substantial 
background current [15]. However, using the in vitro 
calibration, carried out after the removal of the electrode, 
the increases in oxygen current were converted to oxygen 
concentration and gave a mean increase of 39 ± 5.5 µM; 
taking basal oxygen concentrations as 50 µM [23] this 
gives a percentage increase of 78 ± 11% above basal. The 
time for return to basal of the oxygen current was 9.8 ± 3 
min; at no time was there a decrease below basal levels.  
 
In a separate group of rats changes in ECF glucose were 
measured at a glucose biosensor implanted in the right 
striatum. In contrast to rCBF and tissue oxygen, the 
application of the tail pinch produced a decrease in the 
glucose current of 0.86 ± 0.21 from a mean basal value of 
15.3 ± 2.1 nA (n = 11), which represents a decrease of 5.2 
± 0.9% (see Figure 3C). On removal of the paper clip the 
glucose current began to rise and reached a peak of 1.8 ± 
0.3 nA above basal 10 ± 3 min after the end of the tail 
pinch, which represents a peak increase of 11.3 ± 1.1%. 
The time of return to basal glucose current was 30 ± 3 
min, and occasionally glucose levels fell below basal. 
Using the in vitro calibration curve the changes in glucose 
can be converted to concentrations; this gives a mean 
decrease of 16.2 ± 2.5 µM and a mean increase of 34.1 ± 
4.3 µM.  
 
Another group of rats implanted with a combined glucose 
biosensor and dialysis probe were given a 5 min tail pinch 
while the dialysis probe was perfused with aCSF. This, 
once again, produced an initial reduction in extracellular 
glucose, which was co-extensive with the period of 
stimulation, followed by a delayed and long-lasting 
increase in glucose (see Figure 4A). The tail pinch 
stimulus was repeated after the addition to the perfusion 
fluid of the β-adrenoceptor antagonist propranolol to a 
final concentration of 50 µM. This produced the changes 
in glucose illustrated in Figure 4B. Using the calibration 
of the glucose electrode, current values were converted to 
glucose concentrations. There was no effect on basal 
glucose (see Figure 4). The initial decrease in glucose 
during neuronal activation, in the presence of aCSF, was 
–10.5 ± 2.4 µM (n = 8) or 3.4 ± 0.7% of basal. This was 
increased to –16.6 ± 3.2 µM (n = 8) or 5.3 ± 0.6% in the 
presence of propranolol (P = 0.08). The delayed increase 
in glucose following activation, in the presence of aCSF, 
was +44.6 ± 4.4 µM (n = 9) or 13.7 ± 1.4% of basal. This 
was reduced to +1.2 ± 6.4 µM (n = 9) or 4.5 ± 0.6% of 
basal in the presence of propranolol (P = 0.0015). The 
early decrease in glucose during neuronal stimulation is 
probably partly masked by the onset of the delayed 
increase; when this is depressed the early decrease is 
enhanced. 
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Figure 3. A & B: Simultaneous measurement of regional cerebral blood 
flow (rCBF, A) using the H2 clearance technique (Pt electrode), and 
tissue O2 (B) using a carbon paste electrode, in rat striatum in response 
to neuronal stimulation (5 min tail pinch, TP). 
C: The effect of a 5 min tail pinch on brain extracellular glucose levels 
recorded in real time in the striatum of a freely moving rat using a 
microelectrochemical glucose biosensor.  
Note the dissociation between the glucose and rCBF/O2 responses 
during the period of behavioural activation. 
 
Tail pinch increases neuronal activation in the striatum as  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. The effect of a 5-min tail pinch on brain extracellular glucose 
levels recorded in the striatum of a freely moving rat using a 
Pt/PPD/GOx glucose biosensor combined with a microdialysis probe. 
A: Glucose changes during perfusion with aCSF. Mean basal 
concentration, 329 ± 15 µM 
B: Glucose changes during perfusion with 50 µM propranolol. Mean 
basal concentration, 350 ± 27 µM. 
 
shown by the increased release of dopamine and ascorbic 
acid [24]. Co-extensive with the increased neuronal 
activity there was an increase in rCBF. The H2 clearance 
measurements show that the increase in rCBF was rapid 
and began to decline as soon as motor activity ceased. 
The carbon paste electrode gives a continuous measure of 
tissue oxygen, which is a balance between supply and 
utilisation. The close correspondence in the size and time 
course of the increase in rCBF and oxygen, measured as a 
percentage of basal, suggests that the changes in oxygen 
current are simply a reflection of changes in rCBF; there 
appears to be an increase in supply with no change in 
oxygen utilisation. Since at no time does the oxygen 
current decrease below basal level, there appears to be no 
increased oxygen utilisation either before or after the 
increase in rCBF. 
 
Using microdialysis with a sampling time of 2.5 min, it 
has previously been shown that tail pinch induces a brief 
decrease followed by an increase in glucose. As discussed 
above, microdialysis provides an indirect measure of ECF 
glucose which depends on the in vivo recovery which 
cannot be derived from the in vitro probe recovery [25]. 
The glucose oxidase electrode or biosensor provides a 
direct and continuous measure of ECF glucose, which is 
the balance between supply and utilisation. The 5% 
decrease in glucose during the tail pinch, which is very 
similar to the size of the decrease measured with 
microdialysis [4], must represent an increase in 
utilisation, since it occurs during the period of increased 
rCBF and hence presumably is not a fall in glucose 
supply. Furthermore, the absence of an increase in oxygen 
utilisation suggests neuronal aerobic glycolysis. During 
this period there is an increase in extracellular lactate, that 
partly overlaps the decrease in glucose [4]. It is not 
known whether the lactate resulting from neuronal 
glycolysis passes into the ECF. Although there is much 
evidence that lactate is exported by astrocytes and utilised 
by neurones as a metabolic substrate [1], some of the 
extracellular lactate in response to tail pinch could also be 
derived from neuronal glycolysis.  
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At the end of the tail pinch ECF glucose showed a slow 
rise which took 30 min before it returned to baseline 
level. The size of this increase as a percentage of basal is 
also very similar to that seen using microdialysis [4]. This 
delayed increase in glucose must represent increased 
supply rather than decreased utilisation since an increase 
in glucose utilisation by neuronal activation has been 
demonstrated by the use of the 2-deoxyglucose technique 
[26]. This increased supply is severely depressed by 
propranolol, a β-adrenoceptor antagonist. Since 
propranolol has no effect on the increase in local cerebral 
blood flow triggered by neuronal activation [4], and blood 
flow has returned to basal during this late increase in 
glucose, the increase in glucose must come from a 
compartment other than the blood stream. Evidence from 
a number of sources suggests that astrocytes constitute 
this compartment [1, 16]. Astrocytes have a small store of 
glycogen with a rapid turnover rate, which in cultured 
astrocytes is broken down by stimulation of β-
adrenoceptors [7]. It has been shown previously in in vivo 
experiments that local infusion of the β-adrenoceptor 
agonist isoprenaline into the rat striatum causes an 
increase in extracellular glucose [4]. The present results 
suggest that propranolol may be used to distinguish 
between changes in supply and utilisation of glucose and 
support the hypothesis that the stimulated increase in 
glucose in response to neuronal activation is derived from 
astrocytes rather then directly from the blood stream. 
 
There remains the problem of the apparent absence of an 
increase in oxygen utilisation. Since there is little or no 
transport of lactate from brain to blood, the lactate, 
whether derived from neurones or astrocytes must 
ultimately undergo oxidative phosphorylation which 
requires increased oxygen utilisation. At present there is 
no indication when that occurs. Functional magnetic 
resonance imaging (fMRI) depends on the dissociation of 
rCBF and oxygen utilisation in response to neuronal 
activation resulting in an increase in haemoglobin 
saturation. The present results suggest that this applies to 
activation of the striatum. However, there have been 
reports that certain forms of stimulation in certain brain 
regions lead to a parallel increase in rCBF and rCMO2 
[27]; this would make it blind to fMRI. 
 
4  CONCLUSIONS 
The conclusions of this research work can be summarised 
as follows: (a) the Pt/PPD/GOx biosensor provides a 
direct real-time measure of the true extracellular 
concentration of brain glucose; (b) the disparity between 
the changes in glucose and the changes in rCBF and 
oxygen during neuronal activation (tail pinch) suggests 
that extracellular glucose in the brain is not derived 
directly from the blood vascular system but from some 
other source; (c) the fact that proranolol has no effect on 
glucose utilisation but blocks the delivery of glucose 
suggests that astrocytes are the most likely source. 
 
Finally, these experiments emphasise that continuous, 
simultaneous measurement of rCBF, oxygen and glucose, 
provide an important approach to the elucidation of the 
problems of energy supply and utilisation in the brain. 
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